de Renaissance Technologies Cumberland Pharmaceuticals CPIX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 3.1 M | Comprar |
478,263
+7,567
| +2% | +USD 36.3 k | ﹤0.01% | 1719 |
|
|
2026
Q1 | USD 1.53 M | Vender |
470,696
-1,467
| -0.3% | -USD 5.65 k | ﹤0.01% | 2032 |
|
|
2025
Q4 | USD 1.88 M | Vender |
472,163
-43,302
| -8% | -USD 128 k | ﹤0.01% | 1904 |
|
|
2025
Q3 | USD 1.61 M | Comprar |
515,465
+20,502
| +4% | +USD 68.1 k | ﹤0.01% | 2215 |
|
|
2025
Q2 | USD 1.66 M | Vender |
494,963
-8,400
| -2% | -USD 39.8 k | ﹤0.01% | 2233 |
|
|
2025
Q1 | USD 2.13 M | Vender |
503,363
-3,800
| -0.7% | -USD 15.8 k | ﹤0.01% | 1956 |
|
|
2024
Q4 | USD 1.2 M | Vender |
507,163
-21,000
| -4% | -USD 30.9 k | ﹤0.01% | 2388 |
|
|
2024
Q3 | USD 676 k | Vender |
528,163
-10,000
| -2% | -USD 13.8 k | ﹤0.01% | 2648 |
|
|
2024
Q2 | USD 823 k | Vender |
538,163
-4,500
| -0.8% | -USD 7.08 k | ﹤0.01% | 2435 |
|
|
2024
Q1 | USD 912 k | Vender |
542,663
-7,200
| -1% | -USD 14.4 k | ﹤0.01% | 2542 |
|
|
2023
Q4 | USD 985 k | Vender |
549,863
-5,900
| -1% | -USD 10.8 k | ﹤0.01% | 2419 |
|
|
2023
Q3 | USD 1.05 M | Vender |
555,763
-4,980
| -0.9% | -USD 8.34 k | ﹤0.01% | 2257 |
|
|
2023
Q2 | USD 824 k | Vender |
560,743
-10,920
| -2% | -USD 18.8 k | ﹤0.01% | 2584 |
|
|
2023
Q1 | USD 1.12 M | Vender |
571,663
-10,300
| -2% | -USD 24.5 k | ﹤0.01% | 2404 |
|
|
2022
Q4 | USD 1.31 M | Vender |
581,963
-14,900
| -2% | -USD 34.6 k | ﹤0.01% | 2370 |
|
|
2022
Q3 | USD 1.44 M | Vender |
596,863
-25,365
| -4% | -USD 59.7 k | ﹤0.01% | 2264 |
|
|
2022
Q2 | USD 1.29 M | Vender |
622,228
-22,535
| -3% | -USD 52.1 k | ﹤0.01% | 2533 |
|
|
2022
Q1 | USD 1.82 M | Comprar |
644,763
+38,100
| +6% | +USD 127 k | ﹤0.01% | 2296 |
|
|
2021
Q4 | USD 2.83 M | Vender |
606,663
-57,901
| -9% | -USD 197 k | ﹤0.01% | 1885 |
|
|
2021
Q3 | USD 1.78 M | Vender |
664,564
-36,899
| -5% | -USD 110 k | ﹤0.01% | 2174 |
|
|
2021
Q2 | USD 2 M | Vender |
701,463
-51,590
| -7% | -USD 152 k | ﹤0.01% | 2262 |
|
|
2021
Q1 | USD 2.28 M | Comprar |
753,053
+77,894
| +12% | +USD 253 k | ﹤0.01% | 2132 |
|
|
2020
Q4 | USD 1.99 M | Comprar |
675,159
+75,501
| +13% | +USD 229 k | ﹤0.01% | 2114 |
|
|
2020
Q3 | USD 1.92 M | Comprar |
599,658
+200
| +0% | +USD 657 | ﹤0.01% | 2156 |
|
|
2020
Q2 | USD 2 M | Comprar |
599,458
+127,800
| +27% | +USD 465 k | ﹤0.01% | 2189 |
|
|
2020
Q1 | USD 1.71 M | Comprar |
471,658
+2,320
| +0.5% | +USD 10.4 k | ﹤0.01% | 2128 |
|
|
2019
Q4 | USD 2.42 M | Comprar |
469,338
+200
| +0% | +USD 1.06 k | ﹤0.01% | 2230 |
|
|
2019
Q3 | USD 2.78 M | Comprar |
469,138
+27,561
| +6% | +USD 153 k | ﹤0.01% | 2098 |
|
|
2019
Q2 | USD 2.81 M | Comprar |
441,577
+50,800
| +13% | +USD 308 k | ﹤0.01% | 2155 |
|
|
2019
Q1 | USD 2.27 M | Comprar |
390,777
+9,403
| +2% | +USD 54.5 k | ﹤0.01% | 2245 |
|
|
2018
Q4 | USD 2.3 M | Vender |
381,374
-97
| -0% | -USD 580 | ﹤0.01% | 2160 |
|
|
2018
Q3 | USD 2.18 M | Comprar |
381,471
+4,262
| +1% | +USD 25.1 k | ﹤0.01% | 2228 |
|
|
2018
Q2 | USD 2.31 M | Comprar |
377,209
+23,709
| +7% | +USD 148 k | ﹤0.01% | 2195 |
|
|
2018
Q1 | USD 2.36 M | Comprar |
353,500
+23,200
| +7% | +USD 160 k | ﹤0.01% | 2244 |
|
|
2017
Q4 | USD 2.43 M | Comprar |
330,300
+14,295
| +5% | +USD 105 k | ﹤0.01% | 2228 |
|
|
2017
Q3 | USD 2.23 M | Comprar |
316,005
+25,152
| +9% | +USD 174 k | ﹤0.01% | 2244 |
|
|
2017
Q2 | USD 2.04 M | Comprar |
290,853
+20,613
| +8% | +USD 136 k | ﹤0.01% | 2257 |
|
|
2017
Q1 | USD 1.88 M | Comprar |
270,240
+13,240
| +5% | +USD 80.3 k | ﹤0.01% | 2275 |
|
|
2016
Q4 | USD 1.41 M | Comprar |
257,000
+9,900
| +4% | +USD 51.6 k | ﹤0.01% | 2392 |
|
|
2016
Q3 | USD 1.24 M | Comprar |
247,100
+11,800
| +5% | +USD 55.5 k | ﹤0.01% | 2456 |
|
|
2016
Q2 | USD 1.06 M | Comprar |
235,300
+12,700
| +6% | +USD 58.2 k | ﹤0.01% | 2508 |
|
|
2016
Q1 | USD 999 k | Comprar |
222,600
+5,400
| +2% | +USD 25.7 k | ﹤0.01% | 2595 |
|
|
2015
Q4 | USD 1.14 M | Comprar |
217,200
+18,620
| +9% | +USD 106 k | ﹤0.01% | 2401 |
|
|
2015
Q3 | USD 1.15 M | Comprar |
198,580
+1,880
| +1% | +USD 11.7 k | ﹤0.01% | 2313 |
|
|
2015
Q2 | USD 1.41 M | Comprar |
196,700
+26,512
| +16% | +USD 184 k | ﹤0.01% | 2279 |
|
|
2015
Q1 | USD 1.13 M | Comprar |
170,188
+49,288
| +41% | +USD 308 k | ﹤0.01% | 2243 |
|
|
2014
Q4 | USD 723 k | Comprar |
120,900
+36,800
| +44% | +USD 189 k | ﹤0.01% | 2299 |
|
|
2014
Q3 | USD 415 k | Comprar |
84,100
+7,300
| +10% | +USD 35.3 k | ﹤0.01% | 2373 |
|
|
2014
Q2 | USD 346 k | Vender |
76,800
-18,797
| -20% | -USD 83.9 k | ﹤0.01% | 2437 |
|
|
2014
Q1 | USD 430 k | Vender |
95,597
-37,803
| -28% | -USD 180 k | ﹤0.01% | 2401 |
|
|
2013
Q4 | USD 682 k | Vender |
133,400
-44,262
| -25% | -USD 216 k | ﹤0.01% | 2248 |
|
|
2013
Q3 | USD 805 k | Vender |
177,662
-73,206
| -29% | -USD 364 k | ﹤0.01% | 2107 |
|
|
2013
Q2 | USD 1.28 M | Comprar |
+250,868
| Nuevas | +USD 1.25 M | ﹤0.01% | 1811 |
|
Otros fondos que tienen CPIX en su cartera
Posición de Renaissance Technologies en CPIX: resumen de T2 2026
Renaissance Technologies aumentó su participación en Cumberland Pharmaceuticals (CPIX) en 1.6% durante T2 2026, al comprar aproximadamente USD 36.3 k y elevar la posición a 478,263 acciones con un valor de USD 3.1 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1719.
Renaissance Technologies reportó por primera vez una posición en CPIX en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 32 fondos que sigue Wall St. Rank mantienen una posición en CPIX.
- Al cierre de T2 2026, Renaissance Technologies tenía 478,263 acciones de Cumberland Pharmaceuticals con un valor de USD 3.1 M.
- Renaissance Technologies compró 7,567 acciones de Cumberland Pharmaceuticals en T2 2026, por un monto estimado de USD 36.3 k.
- Cumberland Pharmaceuticals representó ﹤0.01% de la cartera de Renaissance Technologies en T2 2026 y fue su posición número 1719.
- Renaissance Technologies reportó por primera vez una posición en Cumberland Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 32 fondos que sigue Wall St. Rank tenían Cumberland Pharmaceuticals en cartera.
Según el Informe 13F de Renaissance Technologies correspondiente a T2 2026, presentado el 13 ago 2026.